The Business Research Company

The Business Research Company’s Multiplex PCR Assays Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, August 19, 2026 /EINPresswire.com/ -- The multiplex PCR assays market is becoming increasingly important in the field of molecular diagnostics, driven by advancements in technology and a growing need for rapid, accurate testing. As healthcare systems worldwide emphasize early disease identification and personalized treatment approaches, this market is set to experience substantial growth and innovation in the coming years.

Multiplex PCR Assays Market Size and Expansion Outlook
The multiplex PCR assays market has seen significant growth in recent years. It is projected to increase from $1.7 billion in 2025 to $1.93 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.4%. This expansion in the past period has been fueled by the rising prevalence of infectious diseases, a growing shift towards molecular diagnostic techniques, limitations associated with singleplex PCR tests, a heightened demand for rapid diagnostic outcomes, and the growth of diagnostic laboratory infrastructure.

Download a free sample of the multiplex pcr assays market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Future Growth Trajectory of the Multiplex PCR Assays Market
Looking ahead, the multiplex PCR assays market is expected to continue its rapid ascent, reaching $3.17 billion by 2030 with a CAGR of 13.2%. The drivers behind this future growth include an increasing emphasis on early disease detection, a surge in demand for all-encompassing diagnostic solutions, the growing implementation of personalized medicine, heightened investments in molecular diagnostics, and wider adoption of multiplex assays for routine testing. Key trends anticipated during this period involve expanded use of multiplex testing for infectious diseases, rising demand for high-throughput diagnostic platforms, greater application of syndromic testing panels, broader incorporation of multiplex PCR in clinical diagnostics, and a preference for cost-efficient multi-target assays.

Understanding Multiplex PCR Assays and Their Benefits
Multiplex PCR assays represent a polymerase chain reaction technique that enables the simultaneous amplification and detection of multiple DNA or RNA targets within a single test. This approach improves testing efficiency by allowing the examination of several genetic markers or pathogens from one sample, leading to more comprehensive and cost-effective diagnostic results.

View the full multiplex pcr assays market report:
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Increasing Demand for Diagnostic Tests as a Major Market Driver
One of the primary factors propelling the multiplex PCR assays market is the growing need for diagnostic testing. These tests are essential in identifying the presence or absence of diseases or conditions in patients. The surge in diagnostic demand is largely due to the rising incidence of chronic diseases such as cancer and diabetes, which require timely and precise diagnosis for better management. Preventive healthcare initiatives also promote regular testing to catch potential health issues early.

How Multiplex PCR Assays Enhance Diagnostic Efficiency
Multiplex PCR technology supports market growth by enabling the simultaneous detection of multiple pathogens or genetic markers from a single sample, thus making diagnostic testing more efficient and thorough. For example, in July 2024, the National Health Service (NHS) in the U.K. reported that diagnostic activities surpassed pre-pandemic levels in 2023, with a 21% increase in tests conducted in May 2024 compared to the previous year. That same month saw 2.4 million diagnostic tests performed, highlighting the growing demand for advanced testing solutions like multiplex PCR assays.

Dominant Geographic Market for Multiplex PCR Assays
In 2025, North America held the largest share in the multiplex PCR assays market. The market report covers several key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive global perspective on market distribution and growth.

Our 2026 market reports now include enhanced strategic insights through:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X